| Organ |
Liver |
Esophagus |
Stomach |
intestine |
| Control |
0.54± 0.08 |
0.63± 0.12
|
0.68± 0.09 |
0.52± 0.11 |
| Sham |
0.67± 0.13 |
0.67± 0.13
|
0.67± 0.13 |
0.67± 0.13 |
| PVL-untreated |
3.17±0.22* |
3±0* |
3±0* |
3±0* |
| Propranolol (75mg/kg) |
2± 0. 17# |
2± 0.17# |
2.33± 0.21*
|
2.33± 0.2*
|
| Ginger(90mg/kg) |
2.33± 0.21# |
2± 0.17# |
1.5± 0.22# |
1.5± 0.22# |
| Ginger(180mg/kg) |
2.33± 0.31# |
2± 0# |
2± 0.17# |
2± 0.17# |
| Ginger (90mg/kg)+ Propranolol |
2± 0. 17# |
1.5± 0.22# |
1.33± 0.21# |
1.33± 0.21# |
| Ginger (180mg/kg)+ Propranolol |
2± 0. 21# |
1.33 ± 0.21# |
2± 0.17# |
2± 0.17# |
|
PVL: Portal vein ligated.
Results are presented as the mean ± S.E.M.
*Significantly different from the corresponding mean value of control and sham group at P<0.05.
# Significantly different from the corresponding mean value of PVL-untreated group and other treatment groups at P<0.05. |
| Table 4: Effect of oral administration of ginger, propranolol or both on histopathological score in the liver, esophagus, stomach and intestine in PVL rats. |
